Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
13.27
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
13.31
+0.04 (0.30%)
After-hours: Dec 5, 2025, 5:27 PM EST
Pulse Biosciences Revenue
Pulse Biosciences had revenue of $86.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $86.00K.
Revenue (ttm)
$86.00K
Revenue Growth
n/a
P/S Ratio
10,456.69
Revenue / Employee
$1,147
Employees
75
Market Cap
899.28M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PLSE News
- 14 days ago - Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Pulse Biosciences, Inc. (PLSE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study - Business Wire
- 6 weeks ago - Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025 - Business Wire
- 2 months ago - Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - Business Wire
- 2 months ago - Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting - Business Wire